EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Evaxion A/S
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$3.33+0.50 (+17.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Evaxion A/S has not reported a dividend
No dividend per share appears in Evaxion A/S's annual filings since fiscal 2017.